Drugs / mRNA-1195.1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05831111 | Apr 2023 → Oct 2026 expected | Epstein-Barr virus infection | ModernaTX, Inc. | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-1195.1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05831111 ↗ |